Literature DB >> 16532085

Lipid profile among diabetes patients in Gaborone, Botswana.

Addisu Y Mengesha1.   

Abstract

A cross-sectional study was undertaken to determine the serum lipid profile of diabetes mellitus (DM) patients receiving treatment at Gaborone City Council clinics. A total of 401 patients were studied over a 3-month period. It was found that 33.5% had hypercholesterolaemia and 38.9% hypertriglyceridaemia. The mean low-density lipoprotein (LDL) levels were higher in females than in males, but there was no difference in LDL levels between type 1 and 2 DM patients. There was no difference in cholesterol, triglyceride and high-density lipoprotein (HDL) levels between genders or between type 1 and 2 patients. Hyperlipidaemia was associated with high body mass index. Only hypertriglyceridaemia was associated with high blood pressure. Hyperlipidaemia was not associated with exercise, smoking or alcohol consumption in the DM patients studied.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532085

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  Dyslipidaemia in a Black African diabetic population: burden, pattern and predictors.

Authors:  William Lumu; Leaticia Kampiire; George Patrick Akabwai; Richard Ssekitoleko; Daniel Ssekikubo Kiggundu; Davis Kibirige
Journal:  BMC Res Notes       Date:  2017-11-09

2.  Active smoking among people with diabetes mellitus or hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Jobert Richie Nansseu; Francky Teddy Endomba; Anderson Ngouo; Jan René Nkeck; Ulrich Flore Nyaga; Arnaud D Kaze; Jean Joel Bigna
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Baye Dagnew; Yigizie Yeshaw; Demeke Geremew; Dessie Abebaw Angaw; Henok Dagne; Mekuriaw Alemayehu; Meseret Derbew Molla; Yonas Akalu
Journal:  Biomed Res Int       Date:  2021-05-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.